You are here
,

GSK's 3-in-1 inhalable drug shows promise in asthma study

  • Friday 3 May 2019
  • Posted by Aftab Ahmad
  • 0 Comments
British drugmaker GlaxoSmithKline Plc said on Thursday that its three-in-one drug Trelegy met the main goal of a late-stage asthma study, signalling a possible boost to its lung medicines division that has been hit by generic competition.


from Reuters: Health News https://reut.rs/2Wk919b

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply